30
CARDIOVASCULAR
hamburger

Suture-Mediated Closure For Both Femoral Arterial And Venous Access Sites

Perclose ProGlide™ Suture-Mediated Closure (SMC) System delivers a secure, non-masking percutaneous suture to the access site that promotes primary healing1 and has no reaccess restrictions.

This system has the broadest arterial and venous indication*; it can be utilized for 5-21F2 (Max. 26F OD4) arterial sheaths and 5-24F3 (Max. 29F OD4) venous sheaths. Abbott’s Perclose ProGlide™ SMC System also offers the following benefits:

  • Reduced time to hemostasis, ambulation and discharge6,10
  • Ability to challenge and confirm closure complete hemostasis on the table
  • Minimized inflammatory response7
  • Significantly lower blood transfusions, infections, mortality and shorter length of stay compared to surgical cutdown for large-bore arterial access8
  • Low major access site-related complications for large-bore venous access9

For EP labs, click here to discover how Perclose ProGlide™ SMC System can improve EP lab workflow and enhance patient experience.

Perclose ProGlide

Broadest Indication*

The Perclose ProGlide™ Suture-Mediated Closure System has the broadest indication for both femoral arterial and venous access.

 

For common femoral access sites

 

  Max. OD
Artery 5–21F2 26F
Vein 5–24F3 29F

Max. OD 26F/0.340 inches/8.62 mm; Max. OD 29F/0.378 inches/9.59 mm. Tests performed by and data on file at Abbott.

Parallels the Surgical Gold Standard
  • Associated with significantly lower blood transfusions, infections, mortality, and shorter length of stay compared to surgical cutdown8
  • Secure repair with pre-tied polypropylene monofilament suture
  • Minimal intravascular footprint
Promotes Vessel Healing
  • Minimizes inflammatory response7
  • No re-access restrictions after using Abbott vascular closure devices
Gives In-Lab Confidence
  • Low access site-related complication,8,9 reduces time to hemostasis, ambulation, and discharge as compared to manual compression6,10
  • Suture repair can be challenged and confirmed on the table
  • Ability to maintain wire access
Suture-Based
Primary Intention Healing

Primary Wound Healing with Suture Repair

Clean Incision

Clean Incision

Early Suture

Early Suture

"Hairline" Scar

References

*As compared to Angio-Seal, ExoSeal, FemoSeal, InClosure, MANTA, Mynx, PerQseal, Vascade, Velox CD, X-Seal. Data on file at Abbott.

  1. Primary intention healing occurs where vessel wall edges are brought together, adjacent to each other. This can be achieved with suture, stitches, staples and clips.
  2. For arterial sheath sizes greater than 8F, at least two devices and the pre-close technique are required.
  3. For venous sheath sizes greater than 8F, at least one device and the pre-close technique are required.
  4. Max. OD 26F/0.340 inches/8.62 mm; Max. OD 29F/0.378 inches/9.59 mm. Tests performed by and data on file at Abbott.
  5. Time to hemostasis, ambulation and discharge applies to the arterial access.
  6. Bhatt, Deepak L. et al. Successful “Pre-Closure” of 7Fr and 8Fr Femoral Arteriotomies With a 6Fr Suture-Based Device (The Multicenter Interventional Closer Registry). American Journal of Cardiology Vol 89. March 2002.
  7. Mercandetti, Michael. Wound Healing and Repair. Medscape. WebMD, 02 April 2019. Web. January 15, 2020.
  8. Perclose ProGlide™ Versus Surgical Closure Outcomes – Real World Evidence. Schneider, Darren B; Krajcer, Zvonimir; et al. LINC 2018.
  9. The Use of the Perclose ProGlide™ Suture Mediated Closure (SMC) Device for Venous Access-Site Closure up to 24F Sheaths. Kar, Saibal; Hermiller, James; et al. CRT 2018.
  10. Applies to arterial access.

MAT-2002004 v2.0

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.

True
accessibility
© 2016 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

accessibility

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.